These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 219129)

  • 1. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
    Glaser M
    J Exp Med; 1979 Mar; 149(3):774-9. PubMed ID: 219129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
    Glaser M
    Cell Immunol; 1979 Dec; 48(2):339-45. PubMed ID: 228870
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
    Ansel S
    Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.
    Röllinghoff M; Starzinski-Powitz A; Pfizenmaier K; Wagner H
    J Exp Med; 1977 Feb; 145(2):455-9. PubMed ID: 299883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus specific antigens in BK virus-transformed cells detected by cell-mediated immune reactions.
    Karjalainen HE; Laaksonen AM; Mäntyjärvi RA
    Med Biol; 1983 Feb; 61(1):73-8. PubMed ID: 6302408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen.
    Gooding LR; O'Connell KA
    J Immunol; 1983 Nov; 131(5):2580-6. PubMed ID: 6313808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune control of SV40-induced tumors in mice.
    Pan S; Abramczuk J; Knowles BB
    Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of specifici immune response against syngeneic SV40-induced tumor-associated antigens by splenectomy.
    Glaser M
    Cell Immunol; 1979 Jun; 45(1):230-6. PubMed ID: 222486
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response to simian virus 40 tumor antigen in nude mice reconstituted with T cells.
    Cicurel L; Croce CM
    J Immunol; 1977 Sep; 119(3):850-4. PubMed ID: 197168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen.
    Knowles BB; Koncar M; Pfizenmaier K; Solter D; Aden DP; Trinchieri G
    J Immunol; 1979 May; 122(5):1798-806. PubMed ID: 87443
    [No Abstract]   [Full Text] [Related]  

  • 16. Inverse relationship between anti-SV40 TASA and anti-H-2 cytotoxic responses.
    De Giovanni C; Grilli S; Lollini PL; Nicoletti G; Prodi G; Nanni P
    J Cancer Res Clin Oncol; 1983; 106(2):117-22. PubMed ID: 6313694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts.
    Warnatz H; Krapf F
    J Immunol; 1976 Sep; 117(3):981-5. PubMed ID: 182884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of H-2 genes associated with T cell-mediated cytotoxic responses to SV40-tumour-associated specific antigens.
    Pfizenmaier K; Trinchieri G; Solter D; Knowles BB
    Nature; 1978 Aug; 274(5672):691-3. PubMed ID: 209340
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of glycosylation prevents H-2K and D antigen expression on SV40 virus-transformed cells.
    Swaminathan S; Gooding LR
    Eur J Immunol; 1983 Apr; 13(4):335-40. PubMed ID: 6303796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyt phenotype of H-2b CTL effectors and precursors specific for the SV40 transplantation rejection antigen.
    Flyer DC; Anderson RW; Tevethia SS
    J Immunol; 1982 Dec; 129(6):2368-71. PubMed ID: 6292288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.